Ovarian cancer, a multifaceted and potentially lethal malignancy, is the fifth leading cause of cancer-related deaths among women and constitutes a significant health challenge globally.

Ovarian cancer predominantly affects women in postmenopausal stages, although it can occur at any age. The insidious nature of its development, often asymptomatic in the early stages, leads to late diagnosis and a consequently poorer prognosis. The foundational knowledge covered in this whitepaper is critical for healthcare professionals, researchers, and scientists as it shapes clinical approaches and research directions.